Rena ContiProfessor at Boston UniversitySpeaker
Profile
Professor Rena Conti is an Associate Professor of Markets, Public Policy and Law at Questrom School of Business, Boston University. Professor Conti is the co-Director of the Technology Policy and Research Initiative, a joint program between Questrom School of Business and the Law School, and the biopharmaceutical markets co-lead at the Ravi K. Mehrotra Institute for Business Markets and Society at Questrom School of Business. Professor Conti holds a Ph.D. from Harvard University Graduate School of Arts and Sciences in health policy and economics. She was faculty at The University of Chicago between 2006 and 2018. Professor Conti is an internationally recognized expert in the fields of health policy and economics. She has published extensively on biopharmaceutical pricing, competition, and innovation. Professor Conti has testified on the economics of biopharmaceutical markets in hearings held by the U.S. Senate, the U.S. House of Representatives, the U.S. Food and Drug Administration, the Federal Trade Commission and numerous state legislative houses. Professor Conti served as Special Government Advisor to the Centers for Medicare and Medicaid Services (CMS) 2022-2023 and has held additional advisory roles at the U.S. Food and Drug Administration (FDA). Professor Conti served as the lead economist on the establishment of the State of Louisiana’s landmark Subscription Model for Hepatitis C Virus Elimination (HepCfreeLa). Professor Conti currently serves as an appointed member of the New Jersey Drug Affordability Council, the Illinois Sickle Cell Advisory Council on Financing and Access to Sickle Cell Disease Treatment and Other High-Cost Drugs & Treatment, and is an elected member of the Conference on Research in Income and Wealth. She is currently serving as a board member of the Boston University Medical Group. The research of Professor Conti has been featured in The New York Times, the Wall Street Journal, the Washington Post, Bloomberg News, USA Today, the Chicago Tribune, the Boston Globe, the LA Times, 60 Minutes, the Daily Show, Vox, the Atlantic, Statnews, and the Colbert Report, among other print and media outlets. Grants and awards from the National Cancer Institute, the National Institute of Mental Health, the National Institute on Drug Abuse, the National Science Foundation, the Sloan Foundation, the Commonwealth Fund, American Cancer Society, and Arnold Ventures, among other sources, support her research.
Agenda Sessions
The Pharmaceutical Benefit Managers (PBM) Crossroads: Regulatory Pressure, Legal Challenges, and Industry Perspectives
, 11:40amView Session
